Corcept Therapeutics (CORT) Treasury Shares (2013 - 2026)
Corcept Therapeutics (CORT) posted Treasury Shares of $998.0 million for Q2 2026, up 2.18% sequentially from $976.7 million in Q1 2026, and up 15.12% YoY from $866.9 million in Q2 2025.
Corcept Therapeutics (CORT) Treasury Shares (2013 - 2026) Analysis & Trends
Corcept Therapeutics has reported Treasury Shares for 9 years, with the latest figure at $998.0 million in Q2 2026.
- Quarterly Treasury Shares rose 15.12% year-over-year to $998.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $998.0 million (up 15.12% YoY) and the FY2025 annual result came in at $966.6 million, up 38.84% from the prior year.
- Treasury Shares grew to $998.0 million in Q2 2026 per CORT's latest filing, from $976.7 million in the prior quarter.
- Over five years, Treasury Shares peaked at $36.0 million in Q3 2025 and troughed at $200000.0 in Q1 2022.
- A 4-year average of $17.6 million and a median of $23.3 million in 2022 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2022 and 2024: Treasury Shares soared 216.6% in 2022, then rose 5.97% in 2024.
- Over 5 years, Treasury Shares stood at $456.1 million in 2022, then jumped by 39.23% to $635.1 million in 2023, then advanced by 9.62% to $696.2 million in 2024, then soared by 38.84% to $966.6 million in 2025, then rose by 3.25% to $998.0 million in 2026.
- According to Business Quant data, Treasury Shares over the past three periods registered $998.0 million, $976.7 million, and $966.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Corcept Therapeutics | 12.37 Bn | 12.07 Bn | 252.09 Mn | 998.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 998.01 Mn |
| Jun 30, 2026 | 998.01 Mn |
| Mar 31, 2026 | 976.69 Mn |
| Mar 31, 2026 | 976.69 Mn |
| Dec 31, 2025 | 966.59 Mn |
| Dec 31, 2025 | 966.59 Mn |
| Dec 31, 2025 | 1.68 Mn |
| Dec 31, 2025 | 1.68 Mn |
| Sep 30, 2025 | 36.00 Mn |
| Sep 30, 2025 | 36.00 Mn |
| Sep 30, 2025 | 923.29 Mn |
| Sep 30, 2025 | 923.29 Mn |
| Jun 30, 2025 | 35.20 Mn |
| Jun 30, 2025 | 866.93 Mn |
| Jun 30, 2025 | 35.20 Mn |
| Jun 30, 2025 | 866.93 Mn |
| Mar 31, 2025 | 33.50 Mn |
| Mar 31, 2025 | 33.50 Mn |
| Mar 31, 2025 | 744.69 Mn |
| Mar 31, 2025 | 744.69 Mn |